This article is more than 5 years old. Information may no longer be current.
Ora designates senior director in Europe
Click Here to Manage Email Alerts
Ora has appointed Simon Chandler, PhD, as senior director to lead regulatory and clinical operations for Europe, according to a company press release.
He will be based in the U.K.
Chandler has more than 15 years of experience in global clinical and regulatory operations in ophthalmology, focusing on retina and anterior segment indications. He received his bachelor’s degree in molecular biology from the University of Portsmouth and his PhD in epigenetic gene regulation from the University of Southampton.
“Dr. Chandler is a key addition to Ora’s team and brings extensive experience in global clinical and regulatory operations, including overseeing approvals by the FDA, EMA and PMDA. His current experience in gene therapy is highly relevant given the potential of this new therapeutic modality to address unmet patient needs,” Stuart B. Abelson, president and CEO of Ora, said in the release.